Skip to content

Motivational Interview Intervention to Help Patients Formulate Their Goals for Medical Care in the Emergency Department

A Pilot Study to Test the Acceptability and Feasibility of Brief Motivational Interview Intervention to Help Patients Formulate Their Goals for Medical Care in the Emergency Department

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03208530
Enrollment
75
Registered
2017-07-05
Start date
2017-08-01
Completion date
2019-05-31
Last updated
2022-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advance Care Planning, Emergency Service, Hospital, Motivational Interviewing

Brief summary

Test the acceptability and feasibility of a brief motivational interview intervention to facilitate advance care planning (ACP) conversations for older adults with serious co-morbid illness being discharged from the emergency department (ED). The investigators will interview the participants to understand their perception of the intervention and collect patient-reported outcomes data after leaving the ED.

Detailed description

This study is designed to engage seriously ill older adults in conversations about their goals of care. Our intervention is intended to help these patients understand the significance of ED visits in the course of their illnesses.

Interventions

BEHAVIORALBrief motivational interview intervention

A brief (\<7minutes) interview by an emergency department clinician to empower patients to formulate and communicate their goals for medical care with patients' outpatient clinicians.

Sponsors

Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥65 years of age * English-speaking * Capacity to consent * AND ≥1 Serious illness (New York Heart Association stage 3 or 4 heart failure, oxygen-dependent chronic obstructive lung disease, chronic kidney disease on dialysis, and metastatic cancer.) OR determined by the emergency department provider that the patient has a high likelihood of death in the next 12 months (I would not be surprised if this patient died in the next 12 months.).

Exclusion criteria

* Acute physical or emotional distress * Determined by emergency department provider not to be appropriate * Clearly documented goals for medical care already exists (e.g. medical order for life sustaining treatment - MOLST). * Already enrolled in this study

Design outcomes

Primary

MeasureTime frameDescription
Number of Patients Who Found the Intervention Acceptable and Provided Suggestions for ImprovementImmediately following the intervention in the emergency department.The investigator will measure quantitatively and qualitatively whether patients found this intervention acceptable and provided suggestions for its improvement.

Secondary

MeasureTime frameDescription
Acceptability of the Intervention by Administering Clinicians.Immediately following the intervention in the emergency department.The investigators will ask the emergency department clinicians who administered the intervention to report the intervention acceptability using a Likert scale survey.
Patient's Quality of LifeAt baseline (in-person) and 1 month after (over the phone) the intervention.The investigators will measure patient's quality of life using a validated survey measure (Quality of life at the end of life, QUAL-E, Steinhauser et al. 2004) at baseline and after the intervention. QUAL-E consists of 25-items and measures 4 domains (symptom impact, relationship with the healthcare provider, preparation for the end of life, and life completion). Each item is in a 5-point Likert scale ranging from (1 Not at all to 5 Completely), and lower scores indicate better outcomes for all domains except for the preparation for the end of life domain and life completion domain where higher scores indicate better outcomes. The mean composite score is compared between baseline and 1 month after the intervention.
Advance Care Planning Engagement BehaviorAt baseline (in-person) and 1 month after (over the phone) the intervention.The investigators will measure patient's behaviors and actions for completing advance care planning using a validated survey measure (advance care planning engagement survey, Sudore et al 2017) at baseline and after the intervention. The measure is a 4-item survey measuring actions and behaviors of advance care planning. The additive composite score is calculated and ranges from 1 (least engagement) to 5 (most engagement).
Patient EmpowermentAt baseline (in-person) and 1 month after (over the phone) the intervention.The investigators will measure patient empowerment by using a validated survey measure (Patient Activation Measure, PAM™) at baseline and after the intervention.
Patient DistressWithin 7 days after the intervention.The investigators will measure patient anxiety/distress regarding a particular event (in this case, our intervention) by using a validated survey measure (Impact of Event Scale - Revised, IES-R, Weiss 1996) within a week after the intervention. IES-R is a 22-item, 5-point Likert scale measure (ranging from 0 Not at all to 4 Extremely). Results consist of the mean rating for the total score and raw scores for three subscales: The Avoidance Scale, Intrusion Scale, and the Hyperarousal Scale. The scores give an indication of the level of impairment from post traumatic stress, where: 0 = No symptoms 1 = Few symptoms 2 = Moderate symptoms 3 = A High level of symptoms 4 = An Extremely high level of symptoms

Countries

United States

Participant flow

Participants by arm

ArmCount
Intervention Arm
This is a single arm study with all enrolled patients receiving the same brief motivational interview intervention. Brief motivational interview intervention: A brief (\<7minutes) interview by an emergency department clinician to empower patients to formulate and communicate their goals for medical care with patients' outpatient clinicians.
75
Total75

Baseline characteristics

CharacteristicIntervention Arm
Age, Continuous72.68 years
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
2 Participants
Race (NIH/OMB)
Black or African American
9 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants
Race (NIH/OMB)
White
60 Participants
Region of Enrollment
United States
75 Participants
Sex: Female, Male
Female
39 Participants
Sex: Female, Male
Male
36 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
5 / 75
other
Total, other adverse events
0 / 75
serious
Total, serious adverse events
0 / 75

Outcome results

Primary

Number of Patients Who Found the Intervention Acceptable and Provided Suggestions for Improvement

The investigator will measure quantitatively and qualitatively whether patients found this intervention acceptable and provided suggestions for its improvement.

Time frame: Immediately following the intervention in the emergency department.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention ArmNumber of Patients Who Found the Intervention Acceptable and Provided Suggestions for Improvement48 Participants
Secondary

Acceptability of the Intervention by Administering Clinicians.

The investigators will ask the emergency department clinicians who administered the intervention to report the intervention acceptability using a Likert scale survey.

Time frame: Immediately following the intervention in the emergency department.

Population: The clinicians administrating the intervention are part of the research team and are not subjects of the clinical trial per NIH definition because they are not prospectively assigned to an intervention (they are the intervention itself), and the outcomes assessed from them were not health-related. The mean acceptability using a Likert scale (0 not acceptable, 1-4 somewhat unacceptable, 6-9 somewhat acceptable, and 10 completely acceptable).

ArmMeasureValue (MEAN)Dispersion
Intervention ArmAcceptability of the Intervention by Administering Clinicians.7 score on a scaleStandard Deviation 1
Secondary

Advance Care Planning Engagement Behavior

The investigators will measure patient's behaviors and actions for completing advance care planning using a validated survey measure (advance care planning engagement survey, Sudore et al 2017) at baseline and after the intervention. The measure is a 4-item survey measuring actions and behaviors of advance care planning. The additive composite score is calculated and ranges from 1 (least engagement) to 5 (most engagement).

Time frame: At baseline (in-person) and 1 month after (over the phone) the intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Intervention ArmAdvance Care Planning Engagement BehaviorPost-intervention (3 month)4.3 score on a scaleStandard Deviation 0.9
Intervention ArmAdvance Care Planning Engagement BehaviorBaseline3.8 score on a scaleStandard Deviation 0.8
Secondary

Patient Distress

The investigators will measure patient anxiety/distress regarding a particular event (in this case, our intervention) by using a validated survey measure (Impact of Event Scale - Revised, IES-R, Weiss 1996) within a week after the intervention. IES-R is a 22-item, 5-point Likert scale measure (ranging from 0 Not at all to 4 Extremely). Results consist of the mean rating for the total score and raw scores for three subscales: The Avoidance Scale, Intrusion Scale, and the Hyperarousal Scale. The scores give an indication of the level of impairment from post traumatic stress, where: 0 = No symptoms 1 = Few symptoms 2 = Moderate symptoms 3 = A High level of symptoms 4 = An Extremely high level of symptoms

Time frame: Within 7 days after the intervention.

Population: We stopped collecting this outcome after the first 8 patients because patients did not express any clinically meaningful anxiety/distress due to our intervention. Furthermore, a much more traumatic event for these patients seemed to be the recent emergency department visit or hospitalization, which made this scale not appliable.

ArmMeasureGroupValue (MEAN)Dispersion
Intervention ArmPatient DistressSubscale - Intrusion0.70 score on a scaleStandard Deviation 0.61
Intervention ArmPatient DistressSubscale - Avoidance0.86 score on a scaleStandard Deviation 1.19
Intervention ArmPatient DistressTotal Score0.66 score on a scaleStandard Deviation 0.63
Intervention ArmPatient DistressSubscale - Hyperarousal0.33 score on a scaleStandard Deviation 0.31
Secondary

Patient Empowerment

The investigators will measure patient empowerment by using a validated survey measure (Patient Activation Measure, PAM™) at baseline and after the intervention.

Time frame: At baseline (in-person) and 1 month after (over the phone) the intervention.

Population: We did not collect this outcome as the advance care planning engagement survey was felt to be better suited for this study.

Secondary

Patient's Quality of Life

The investigators will measure patient's quality of life using a validated survey measure (Quality of life at the end of life, QUAL-E, Steinhauser et al. 2004) at baseline and after the intervention. QUAL-E consists of 25-items and measures 4 domains (symptom impact, relationship with the healthcare provider, preparation for the end of life, and life completion). Each item is in a 5-point Likert scale ranging from (1 Not at all to 5 Completely), and lower scores indicate better outcomes for all domains except for the preparation for the end of life domain and life completion domain where higher scores indicate better outcomes. The mean composite score is compared between baseline and 1 month after the intervention.

Time frame: At baseline (in-person) and 1 month after (over the phone) the intervention.

Population: Patients found this survey too long to complete when they just left the emergency department after acute health decline. Further, the questions were making patients think more about the end of life, which may skew our aim. Therefore, we decided to stop collecting this outcome after the first 9 patients. Only 3 out of those 9 participants completed their 1-month QUAL-E assessment.

ArmMeasureGroupValue (MEAN)Dispersion
Intervention ArmPatient's Quality of LifeBaseline Overall Score (Mean)3.69 score on a scaleStandard Deviation 0.28
Intervention ArmPatient's Quality of Life1-month Overall Score (Mean)3.72 score on a scaleStandard Deviation 0.2
Intervention ArmPatient's Quality of LifeBaseline Symptoms Impact Subscale (Mean)3.70 score on a scaleStandard Deviation 0.14
Intervention ArmPatient's Quality of Life1-month Symptoms Impact Subscale (Mean)3.00 score on a scaleStandard Deviation 0.98
Intervention ArmPatient's Quality of LifeBaseline Relationship with Healthcare Provider Subscale (Mean)4.00 score on a scaleStandard Deviation 0.71
Intervention ArmPatient's Quality of Life1-month Relationship with Healthcare Provider Subscale (Mean)4.40 score on a scaleStandard Deviation 0.6
Intervention ArmPatient's Quality of LifeBaseline Preparation for the End of Life Subscale (Mean)2.60 score on a scaleStandard Deviation 0.31
Intervention ArmPatient's Quality of Life1-month Preparation for the End of Life Subscale (Mean)2.58 score on a scaleStandard Deviation 0.96
Intervention ArmPatient's Quality of LifeBaseline Life Completion Subscale (Mean)4.00 score on a scaleStandard Deviation 0.33
Intervention ArmPatient's Quality of Life1-month Life Completion Subscale (Mean)4.14 score on a scaleStandard Deviation 0.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026